 Oxford Immunotec Global NASDAQ:OXFD was upgraded by Zacks Investment Research from a hold rating to a strong-buy rating in a report issued on Thursday, Zacks.com reports. The firm currently has a 15.00 price target on the stock. Zacks Investment Researchs target price would indicate a potential upside of 23.05 from the companys current price. According ... 